Lung cancer is one of the most common malignant tumor in the world. Radiotherapy and Chemotherapy are the standard treatments of Lung Cancer, but the patient survival time remains at a lower level. Studies found that the tumor’s occurrence and development relay on angiogenesis. Vascular Endothelial Growth Factor and its receptor are important angiogenesis adjustment factors,which are involved in tumor formation and development of multiple processes.Anti-angiogenesis therapy opens up new avenues for the treatment of Lung Cancer . The paper make a summary of the research present situation and progress of anti-angiogenesis therapy for Lung cancer.